Macitentan and Brain abscess - a phase IV clinical study of FDA data

Summary:

Brain abscess is found among people who take Macitentan, especially for people who are male, 30-39 old.

The phase IV clinical study analyzes which people take Macitentan and have Brain abscess. It is created by eHealthMe based on reports of 6,355 people who have side effects when taking Macitentan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

6,355 people reported to have side effects when taking Macitentan.
Among them, 6 people (0.09%) have Brain abscess.


What is Macitentan?

Macitentan has active ingredients of macitentan. eHealthMe is studying from 6,358 Macitentan users for its effectiveness, alternative drugs and more.

What is Brain abscess?

Brain abscess is found to be associated with 764 drugs and 546 conditions by eHealthMe.

Number of Macitentan and Brain abscess reports submitted per year:

Could Macitentan cause Brain abscess?

Gender of people who have Brain abscess when taking Macitentan *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Brain abscess when taking Macitentan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Macitentan *:

  1. Remodulin: 6 people, 100.00%
  2. Opsumit: 1 person, 16.67%
  3. Adcirca: 1 person, 16.67%

Common side effects people have besides Brain abscess *:

  1. Infusion Site Pain: 6 people, 100.00%
  2. Infusion Site Erythema (reddening of the skin at infusion site): 6 people, 100.00%
  3. Infusion Site Induration: 4 people, 66.67%
  4. Infusion Site Hypersensitivity: 3 people, 50.00%
  5. Infusion Site Discoloration: 2 people, 33.33%
  6. Infusion Site Dermatitis: 2 people, 33.33%

Common conditions people have *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Macitentan and have Brain abscess?

Check whether Brain abscess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Brain abscess and when was it recovered:

Expand to all the drugs that have ingredients of macitentan:

Alternative drugs to, pros and cons of Macitentan:

Common Macitentan side effects:

Browse all side effects of Macitentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Brain abscess treatments and more:

COVID vaccines that are related to Brain abscess:

Common drugs associated with Brain abscess:

All the drugs that are associated with Brain abscess:

Common conditions associated with Brain abscess:

All the conditions that are associated with Brain abscess:

How the study uses the data?

The study uses data from the FDA. It is based on macitentan (the active ingredients of Macitentan) and Macitentan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: